Clopidogrel is a potent inhibitor of platelet aggregation and has been used as an alternative,
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …

Objective: Challenging differential diagnosis Background: Clopidogrel is an antiplatelet
medication that plays an important role in primary management and secondary prevention of …

■ Summary We report a case of a 76-year-old-man who developed spontaneous
hemarthrosis of his right knee following clopidogrelaspirin treatment. Clopidogrel is an ADP …

A 54-year-old Japanese man was urgently admitted to our hospital because of “unmovable”
polyarthralgia, high fever and pruritus. He had taken clopidogrel 3 weeks before this …

Purpose A case of acute polyarthritis associated with the use of clopidogrel is reported.
Summary A 72-year-old retired Caucasian man arrived at the emergency department with …

Clopidogrel is a thienopyridine derivative antiplatelet compound. The antiplatelet effects of
clopidogrel originate through noncompetitive antagonism of the platelet ADP receptor …

Clopidogrel is an oral thienopyridine and together with aspirin is a component of dual
antiplatelet therapy for the prevention of stent thrombosis after intracoronary stent …

Clopidogrel is an oral thienopyridine antiplatelet agent thath selectively and irreversibly
inhibits the platelet ADP receptor and the subsequent ADP-mediated activation of the …

Background Clopidogrel is an adenosine diphosphate receptor antagonist used in patients
with atherosclerotic vascular disease to reduce the incidence of ischemic events. Case …

Clopidogrel belongs to a new class of adenosine dipho-sphate (ADP) receptor antagonists
employed for the prevention of ischaemic stroke and myocardial infarction. We describe a …